Author: Kristy Licari

ITHACA, N.Y., Nov. 11, 2016 — Advion, Inc., a leading systems and consumables developer for the life sciences industry, announced today that Accurate Mass Scientific P/L will become its Australian distributor, effective immediately. Directed by Dr. George Khairallah, the partnership will expand Advion’s strength in mass spectrometry within the Australian market. Dr. Khairallah has 18 years of experience in biotechnology research and mass spectrometry with over 80 publications.

“The opportunity to work with a technology leader like Dr. Khairallah and the Accurate Mass Scientific team is yet another way Advion continues to enhance its distribution channels while providing first class local customer support,” said David B. Patteson, Advion CEO. “After recently reaching a milestone with the sale of our 500th Expression compact mass spectrometer and 750th TriVersa NanoMate automated ion source, it is clear strategic partnerships are needed to ensure global demand is met with local excellence.”

To contact Dr. George Khairallah and the Accurate Mass Scientific team, please direct your inquiries to george@accuratems.com, Phone/Fax: +61-3-9323 1688, mobile : +61 0401 484846, or visit www.AccurateMS.com.

###

About Advion, Inc.
Advion develops, manufactures and globally supports mass spectrometers, chip-based ion sources, microfluidic flow chemistry systems and consumables for life science and related industries. We seek to enhance analysis performance and workflows. Using our deep scientific and engineering knowledge of mass spectrometry and microfludics, we leverage our passionate employees’ commitment to create quality, flexible and fit-for-purpose solutions. More about Advion, Inc. can be found on our website, www.advion.com.

Press Contact:
Kristy Mitchell
Director of Marketing, Advion, Inc.
Direct: 607-882-9903
kmitchell@advion.com

ITHACA, N.Y., Sept. 27, 2016 /PRNewswire/ — Advion, Inc., a leading systems and consumables developer for the life sciences industry, announced that, during the quarter ending September 30, 2016, it had shipped its 500th Compact Mass Spec (CMS), with the milestone order having been received from a leading university in Taiwan, demonstrating the product’s global appeal.  Demand for the product continues to accelerate, with nearly 200 units expected in 2016.

Commenting on the landmark, Advion’s CEO David B. Patteson stated, “Having launched the product line about four years ago, we are exceedingly happy with the market adoption and product adaptation.  In 2012-2013, we quickly reached about 10 units per quarter. In 2014 we doubled to 20+/quarter.  In 2015, we exceeded 35/quarter, and this year we rose to 40-50/quarter and continue climbing. Equally rewarding are the workflow integration expansions and customer innovations.  We are routinely utilized in multiple modalities, and our easy-to-use CheMS software allows the chemist to choose, via software, which mode they desire without time-consuming setups, changeovers, plumbing or setting reconfigurations. Moreover, our customers have created novel ways to solve assay challenges; two such customer inventions made it to market in 2016:

• The iASAP probe allows chemists to capture and assay, in an inert gas, previously impossible oxidizing inorganic complexes.
• The Volatile Sample System permits Breathomics and Headspace analysis

These are just two examples of creative customers using the CMS in a deployed lab to solve analytical problems, while working with our R&D team to bring solutions to the market for broad mutual benefit.  We see this continuing as our footprint expands.”

Based upon publicly disclosed unit volumes from competitors, it is believed Advion enjoys between 75-85% market share in the synthetic organic, natural product and peptide discovery chemistry deployed lab market.  This position is expected to remain intact, if not grow, due to the company having signed a major OEM contract in Q4 2015, which should add between 30-40 units per annum beginning in October 2016.

###

About Advion, Inc.
Advion develops, manufactures and globally supports mass spectrometers, chip-based ion sources, microfluidic flow chemistry systems and consumables for life science and related industries. We seek to enhance analysis performance and workflows. Using our deep scientific and engineering knowledge of mass spectrometry and microfludics, we leverage our passionate employees’ commitment to create quality, flexible and fit-for-purpose solutions. More about Advion, Inc. can be found on our website, www.advion.com.

Press Contact:
Kristy Mitchell
Director of Marketing, Advion, Inc.
Direct: 607-882-9903
kmitchell@advion.com

March 13, 2016 – Ithaca, NY – Advion, Inc., a leading systems and consumables developer for the life sciences industry, announced during this week’s 251st American Chemical Society National Meeting & Exposition in San Diego, California the introduction of a breakthrough sample introduction technique for its line of expression compact mass spectrometers (CMS). The new iASAP (inert Atmospheric Solids Analysis Probe (ASAP®)) was originally developed at the University of Pennsylvania by Charles McEwen, Ph.D, and enhanced by the Freiberg researchers.

ASAP gives chemists and chemistry students the ability to ionize liquid and solid samples for analysis by mass spectrometer without the need for sample preparation. The technique allows a synthetic chemist to perform real-time reaction monitoring by simply dipping the ASAP probe into their reaction mixture and inserting the probe into the atmospheric pressure chemical ionization (APCI) source of the CMS. Mass spectral data is presented within seconds.

For air-sensitive compounds, such as metal catalysts, iASAP is a viable technique to prevent oxidization and facilitate their assay. Advion credits Professor Ingo Krossing’s group at the Albert-Ludwigs-University of Freiburg (Freiberg) with modifying the ASAP probe to protect the compounds in inert gas as they are transferred to the CMS, enabling such measurements without the traditonal need for glove boxes. Advion and Freiburg negotiated a transfer of the patent estate to Advion to allow global commercialization.

“The best product enhancements come from our users,” says Simon Prosser, Vice President of Marketing. “A large percentage of all synthetic chemistry involves air-sensitive compounds and needs to be carried out in glove boxes or Schlenk lines and Advion is pleased to have collaborated with Prof. Krossing’s group to bring this enhancement to others.”

The iASAP is available for quoting and will begin shipping in May 2016.

March 9, 2016 – Ithaca, NY – Advion, Inc., a leading systems and consumables developer for the life sciences industry, announced during the ABRF 2016 Annual Meeting in Fort Lauderdale, Florida the introduction of a proteins and peptides analysis system, ‘TIDES EXPRESS.  The system combines Advion’s new, easy-to-use, HPLC system with the extended mass range expressionL compact mass spectrometer (CMS).  The new platform improves the workflow of chemists performing peptide synthesis and needing fast mass analysis of each reaction step as well as final products. It is the perfect technique for monitoring reactions in solid phase peptide synthesizers.  Additional fragmentation analysis and charge deconvolution tools also enhance its use for protein characterization.

Solid phase peptide synthesis (SPPS) allows for rapid, parallel synthesis of peptides of various amino acid (AA) lengths, some of which routinely exceed 30 or 40 in length. Although modern SPPS shows a high degree of automation, some SPPS peptide targets remain challenging to synthesize and a single suboptimal synthesis cycle can cause costly re-runs in large scale or long chain protein production – rapid analysis of each reaction step can prevent this.  Mass spectrometry provides both molecular mass and amino acid sequence information through specific and selective molecule fragmentation along the amino acid backbone.  The ‘TIDES EXPRESS includes an easy-to-use HPLC gradient system with manual sample injector, expressionL CMS along with fragmentation analysis and charge deconvolution software tools for easy and excellent data interpretation.

“The complexity of proteins and peptides analysis requires efficient and cost-effective analysis for informed decision making,” says Simon Prosser, Vice President of Marketing.  “The ease-of-use and compact size makes the ‘TIDES EXPRESS ideal for bench-top reaction monitoring of SPPS systems, most of which to-date have been limited to UV or IR monitoring of analytes.”

Advion is now quoting the ‘TIDES EXPRESS and deliveries will begin in mid-April.

October 30, 2015 – Beijing, CHINA – Advion, Inc., a leading systems and consumables developer for the life sciences industry, and operating division of Bohui Innovation Technology, announces that its nano LC ion source, Chip-Mate, received a new product innovation award at this week’s BCEIA conference and exhibition being held this week in Beijing.

While Advion sells and supports its CMS mass spectrometer products directly to end users in China, the company’s exclusive Chinese distribution partner for chip-based nanoelectrospray ion source products (TriVersa NanoMate and Chip-Mate), ASPEC, applied for the award, and was selected from a field of many eligibale applicants.  The award was received by Advion’s CEO, David B. Patteson, during the BCEIA celebration reception.

“ASPEC has been and continues to be a strong partner of Advion’s chip-based nanoelectrospray products in China, and this accolade is a testament to their efforts in the market,” says Mr. Patteson. “With our focus on expanding China, ASPEC will play a key role especially as we launch a series of new nanoESI sources in the coming months and years.”

BCEIA attendees and Beijing locals were invited to visit Bohui/Advion’s booth during the four day show, October 27 – 30. More information about the event is available on the BCEIA website: http://www.bceia.cn/en.

About Advion, Inc.
Advion develops, manufactures and globally supports mass spectrometers, chip-based ion sources, microfluidic flow chemistry systems and consumables for life science and related industries. We seek to enhance analysis performance and workflows. Using our deep scientific and engineering knowledge of mass spectrometry and microfluidics, we leverage our passionate employees’ commitment to create quality, flexible and fit-for-purpose solutions. More about Advion, Inc. can be found on our website, www.advion.com.

About Bohui
Bohui Innovation Technology Co. is a developer, manufacturer, supplier and service provider of diagnostic systems related to women and children’s health.  Its core product line is fully automated blood heavy metal analyzers.  It is committed to developing microfluidic and mass spectrometry technologies for diagnostic and inspection applications.  Bohui is located in Beijing and publically traded in the Chinese stock market.  More about Bohui can be found on our website, www.bohui-tech.com.

For Advion, Inc.
Amy Lummus
Director of Marketing
Advion, Inc.
Telephone: 1.607.379.4565
alummus@advion.com

For Bohui
Min Liu
Secretary of the Board
Bohui Innovation Technology Co.
Telephone: 010 8885 0168
Email: liumin@bohui-tech.com

October 23, 2015 – Ithaca, NY – Advion, Inc., a leading systems and consumables developer for the life sciences industry, announces further expansion into the Chinese chemistry market.

Effective October 26, 2015, Advion will have opened direct sales and support in China with over 25 trained direct sales and support personnel. In addition, Advion will showcase all of its products at China’s largest analytical instrumentation conference, BCEIA. The event is being held October 27 – 30^th in Beijing. The 90 m² exhibit booth space will highlight the expression compact mass spectrometer (CMS) product line, Advion’s chip-based nanoelectrospray ion sources, the NanoTek microfluidic synthesis system, Plate Express TLC/MS interface as well as several mass spectrometry related accessory items.

Further solidifying the synergies between Advion and Bohui, product development continues on a significant mass spectrometry project that will greatly leverage the companies’ market capabilities in clinical applications.

“The Chinese chemistry market is one of the world’s largest and remains greatly underserved. Advion’s new relationship with Bohui provides a unique platform to offer the greatest access and value to end users with local support and expertise,” explains, David B. Patteson, Advion’s President and CEO. “Based upon publicly-released documents from our competitors, we now estimate that Advion maintains perhaps 90% market share in our core synthetic chemistry market segment. Expanding into the Chinese market, Advion offers a meaningful return potential for Bohui shareholders. Advion executives will be at BCEIA from October 21-31 to launch direct sales and support into China.”

BCEIA attendees and Beijing locals are invited to visit Bohui/Advion’s booth during the four day show, October 27 – 30. More information about the event is available on the BCEIA website: http://www.bceia.cn/en

About Advion, Inc.

Advion develops, manufactures and globally supports mass spectrometers, chip-based ion sources, microfluidic flow chemistry systems and consumables for life science and related industries. We seek to enhance analysis performance and workflows. Using our deep scientific and engineering knowledge of mass spectrometry and microfluidics, we leverage our passionate employees’ commitment to create quality, flexible and fit-for-purpose solutions. More about Advion, Inc. can be found on our website, www.advion.com.

About Bohui

Bohui Innovation Technology Co. is a developer, manufacturer, supplier and service provider of diagnostic systems related to women and children’s health. Its core product line is fully automated blood heavy metal analyzers. It is committed to developing microfluidic and mass spectrometry technologies for diagnostic and inspection applications. Bohui is located in Beijing and publically traded in the Chinese stock market. More about Bohui can be found on our website, www.bohui-tech.com.

For Advion, Inc.

Amy Lummus
Director of Marketing
Advion, Inc.
Telephone: 1.607.379.4565
alummus@advion.com

For Bohui

Min Liu
Secretary of the Board
Bohui Innovation Technology Co.
Telephone: 010 8885 0168
Email: liumin@bohui-tech.com

###

August 17, 2015 – Ithaca, NY – Advion, Inc., a leading systems and consumables developer for the life sciences industry, announced during this week’s 250th American Chemical Society National Meeting & Exposition in Boston, Massachusetts the release of software for its  expression compact mass spectrometer (CMS) product line, greatly increasing ease-of-use for mass spectrometry in many chemistry applications. This software, titled CheMS, along with the release of new bundled systems configured specifically for the chemist’s workflows, enables simpler than ever lab-based mass spectrometry.

The development of the expression CMS family is focused on speeding and simplifying the chemist’s workflow by bringing the mass spectrometry analytical experience to chemistry and biochemistry laboratories. The CheMS user interface is the latest in this progression; it allows users to quickly select their desired workflow (Direct Injection, TLC/CMS, or ASAP) and type of compound they wish to analyze in just a few clicks of the mouse. The software automatically optimizes the ion source and data acquisition parameters to ensure they get the data they need. This allows the chemist to obtain optimal analytical data without needing to be an expert in mass spectrometry.

“Advion is focused on developing technology that improves user workflow and increases productivity; feedback from our customers led us to another dynamic product enhancement dramatically improving the laboratory experience,” says Simon Prosser, Vice President of Marketing.  “Mass spectrometers provide more information than nearly any other detector, but have historically seen limited use in chemistry laboratories because of their previous complexity. We strive to make them easier and faster to use, and Advion’s novel software platform allows the chemist to focus on optimizing their reactions, not the mass spectrometry.”

Advion will begin deliveries of CheMS in fourth quarter of 2015, and is demonstrating the product and its new bundled systems at Advion’s booth (#414) during this week’s ACS National Meeting & Exposition.

About Advion, Inc.
Advion develops, manufactures and globally supports mass spectrometers, chip-based ion sources, microfluidic flow chemistry systems and consumables for life science and related industries. We seek to enhance analysis performance and workflows. Using our deep scientific and engineering knowledge of mass spectrometry and microfluidics, we leverage our passionate employees’ commitment to create quality, flexible and fit-for-purpose solutions. More about Advion, Inc. can be found on our website, www.advion.com.

About Bohui
Bohui Innovation Technology Co. is a developer, manufacturer, supplier and service provider of diagnostic systems related to women and children’s health.  Its core product line is fully automated blood heavy metal analyzers.  It is committed to developing microfluidic and mass spectrometry technologies for diagnostic and inspection applications.  Bohui is located in Beijing and publically traded in the Chinese stock market.  More about Bohui can be found on our website, www.bohui-tech.com.

For Advion, Inc.
Amy Lummus
Director of Marketing
Advion, Inc.
Telephone: 1.607.379.4565
alummus@advion.com

For Bohui
Min Liu
Secretary of the Board
Bohui Innovation Technology Co.
Telephone: 010 8885 0168
Email: liumin@bohui-tech.com